» Articles » PMID: 37701941

Natural Human Bet V 1-specific IgG Antibodies Recognize Non-conformational Epitopes Whereas IgE Reacts with Conformational Epitopes

Abstract

Background: The nature of epitopes on Bet v 1 recognized by natural IgG antibodies of birch pollen allergic patients and birch pollen-exposed but non-sensitized subjects has not been studied in detail.

Objective: To investigate IgE and IgG recognition of Bet v 1 and to study the effects of natural Bet v 1-specific IgG antibodies on IgE recognition of Bet v 1 and Bet v 1-induced basophil activation.

Methods: Sera from birch pollen allergic patients (BPA, n = 76), allergic patients without birch pollen allergy (NBPA, n = 40) and non-allergic individuals (NA, n = 48) were tested for IgE, IgG as well as IgG and IgG reactivity to folded recombinant Bet v 1, two unfolded recombinant Bet v 1 fragments comprising the N-terminal (F1) and C-terminal half of Bet v 1 (F2) and unfolded peptides spanning the corresponding sequences of Bet v 1 and the apple allergen Mal d 1 by ELISA or micro-array analysis. The ability of Bet v 1-specific serum antibodies from non-allergic subjects to inhibit allergic patients IgE or IgG binding to rBet v 1 or to unfolded Bet v 1-derivatives was assessed by competition ELISAs. Furthermore, the ability of serum antibodies from allergic and non-allergic subjects to modulate Bet v 1-induced basophil activation was investigated using rat basophilic leukaemia cells expressing the human FcεRI which had been loaded with IgE from BPA patients.

Results: IgE antibodies from BPA patients react almost exclusively with conformational epitopes whereas IgG, IgG and IgG antibodies from BPA, NBPA and NA subjects recognize mainly unfolded and sequential epitopes. IgG competition studies show that IgG specific for unfolded/sequential Bet v 1 epitopes is not inhibited by folded Bet v 1 and hence the latter seem to represent cryptic epitopes. IgG reactivity to Bet v 1 peptides did not correlate with IgG reactivity to the corresponding Mal d 1 peptides and therefore does not seem to be a result of primary sensitization to PR10 allergen-containing food. Natural Bet v 1-specific IgG antibodies inhibited IgE binding to Bet v 1 only poorly and could even enhance Bet v 1-specific basophil activation.

Conclusion: IgE and IgG antibodies from BPA patients and birch pollen-exposed non-sensitized subjects recognize different epitopes. These findings explain why natural allergen-specific IgG do not protect against allergic symptoms and suggest that allergen-specific IgE and IgG have different clonal origin.

Citing Articles

Long-chain fatty acids block allergic reaction against lipid transfer protein Sola l 7 from tomato seeds.

Parron-Ballesteros J, Martin-Pedraza L, Gordo R, Mayorga C, Pastor-Vargas C, Titaux-Delgado G Protein Sci. 2024; 33(9):e5154.

PMID: 39180496 PMC: 11344279. DOI: 10.1002/pro.5154.


The Potential of Human Monoclonal IgE Antibodies to Establish Biological Potency and Stability of Allergen Extracts.

Rabin R Curr Allergy Asthma Rep. 2024; 24(9):471-475.

PMID: 39046600 PMC: 11364621. DOI: 10.1007/s11882-024-01168-4.


Whence and wherefore IgE?.

Rahman R, Wesemann D Immunol Rev. 2024; 326(1):48-65.

PMID: 39041740 PMC: 11436312. DOI: 10.1111/imr.13373.


Heterogenous Induction of Blocking Antibodies against Ragweed Allergen Molecules by Allergen Extract-Based Immunotherapy Vaccines.

Zbircea L, Buzan M, Grijincu M, Cotarca M, Tamas T, Haidar L Vaccines (Basel). 2024; 12(6).

PMID: 38932364 PMC: 11209568. DOI: 10.3390/vaccines12060635.


The cytoskeletal protein profilin is an important allergen in saltwort ().

Peterkova L, Trifonova D, Gattinger P, Focke-Tejkl M, Garib V, Magbulova N Front Immunol. 2024; 15:1379833.

PMID: 38911871 PMC: 11190152. DOI: 10.3389/fimmu.2024.1379833.


References
1.
Brazhnikov G, Smolnikov E, Litovkina A, Jiang T, Shatilov A, Tulaeva I . Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes. Allergy. 2023; 78(12):3136-3153. PMC: 10952721. DOI: 10.1111/all.15865. View

2.
Akdis C, Blesken T, Wymann D, Akdis M, Blaser K . Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants. Eur J Immunol. 1998; 28(3):914-25. DOI: 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO;2-C. View

3.
Shamji M, Kappen J, Akdis M, Jensen-Jarolim E, Knol E, Kleine-Tebbe J . Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy. 2017; 72(8):1156-1173. DOI: 10.1111/all.13138. View

4.
Ogulur I, Pat Y, Ardicli O, Barletta E, Cevhertas L, Fernandez-Santamaria R . Advances and highlights in biomarkers of allergic diseases. Allergy. 2021; 76(12):3659-3686. PMC: 9292545. DOI: 10.1111/all.15089. View

5.
Shamji M, Singh I, Layhadi J, Ito C, Karamani A, Kouser L . Passive Prophylactic Administration with a Single Dose of Anti-Fel d 1 Monoclonal Antibodies REGN1908-1909 in Cat Allergen-induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial. Am J Respir Crit Care Med. 2021; 204(1):23-33. PMC: 8437124. DOI: 10.1164/rccm.202011-4107OC. View